Used in neuroscience and clinical research to quantify S100B protein levels in biological samples such as serum, plasma, and cerebrospinal fluid. The kit is commonly applied in studies related to brain injury, including traumatic brain injury (TBI) and stroke, where elevated S100B levels serve as a biomarker for glial activation and blood-brain barrier disruption. It is also utilized in monitoring neurodegenerative conditions, neonatal hypoxia, and central nervous system tumors. Due to its high sensitivity and specificity, this ELISA kit supports research in assessing neuronal damage and evaluating therapeutic interventions in both human and animal models.